aplastic anemia | Page 56 | Aplastic Anemia & MDS International Foundation

aplastic anemia

Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network.

Author(s): 
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, DiFronzo N, Horowitz MM, Antin JH.
Primary Author: 
Pulsipher MA
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Oct 2010

Although recent advances in therapy offer the

Bone Marrow Diseases: 

Comparison of Outcomes after Transplantation of G-CSF-Stimulated Bone Marrow Grafts versus Bone Marrow or Peripheral Blood Grafts from HLA-Matched Sibling Donors for Patients with Severe Aplastic Anemia.

Author(s): 
Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, Isola L, Ispizua AU, Lazarus H, Marsh J, Russell J, Sabloff M, Waller EK, Eapen M.
Primary Author: 
Chu R
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Oct 2010

We compared outcomes of patients with severe

Bone Marrow Diseases: 

Comparison between Matched Related and Alternative Donors of Allogeneic Hematopoietic Stem Cells Transplanted into Adult Patients with Acquired Aplastic Anemia: Multivariate and Propensity Score-Matched Analysis.

Author(s): 
Kim H, Kim BS, Kim DH, Hyun MS, Kim SH, Bae SH, Choi JH, Sohn SK, Shin HJ, Won JH, Yoon SS, Jo DY, Joo YD, Park JH, Lee KH; on behalf of The Korean Society of Blood and Marrow Transplantation.
Primary Author: 
Kim H
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Jan 2011

We retrospectively compared the outcomes of 225

Bone Marrow Diseases: 

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation.

Author(s): 
Tichelli A, Schrezenmeier H, Socié G, Marsh J, Bacigalupo A, Dührsen U, Franzke A, Hallek M, Thiel E, Wilhelm M, Höchsmann B, Barrois A, Champion K, Passweg JR
Primary Author: 
Tichelli A
Journal Title: 
Blood
Original Publication Date: 
Apr 2011

We evaluated the role of granulocyte colony-stimulating factor (G-CSF) in patients with severe

Bone Marrow Diseases: